Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 10 of 10 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/12/21
End: 04/14/23
Due: 04/14/24
Phase: N/A
Priority: Normal
Start: 03/09/22
End: 10/06/22
Due: 10/06/23
Phase: N/A
Priority: Normal
Start: 10/31/13
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 06/18/21
End: 09/09/24
Due: 09/09/25
Phase: N/A
Priority: Normal
Start: 10/02/24
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 10/02/17
End: 11/21/19
Due: 11/21/20
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 12/31/19
Due: 12/31/20
A Study to Evaluate the Safety and Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica
Phase: N/A
Priority: Normal
Start: 11/07/18
End: 02/25/20
Due: 02/25/21
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 03/30/16
Due: 03/30/17
Phase: N/A
Priority: Normal
Start: 02/26/18
End: 06/04/18
Due: 06/04/19